Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DARE compared with OBAI: revenue, margins and what each company keeps, and the suppliers and customers both name
DARE
Dare Bioscience, Inc.
Change
Mkt cap
Revenue
Revenue
OBAI
Our Bond, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DARE
Dare Bioscience, Inc.
vs
OBAI
Our Bond, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
DARE
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▼
−32.12%
—
OBAI
No earnings history for OBAI.
= implied
DARE realized, solid
OBAI realized, hatched
One scale, both sides: full bar = 33%
× = |realized| ÷ implied
Source: market data
DARE
Dare Bioscience, Inc.
Change
0.65
▲
+4.10%
· post 0.64
Mkt cap
$9.8M
Revenue
$187,546
Q2 FY26
OBAI
Our Bond, Inc.
Change
1.68
▼
−5.62%
· post 1.64
Closed
Nov 6 '26
Mkt cap
$2.1M
Revenue
$2M
Q2 FY26
vs
Compare
Closed
Nov 6 '26
DARE
Dare Bioscience, Inc.
vs
OBAI
Our Bond, Inc.
0.65
▲
+4.10%
post 0.64
Price
1.68
▼
−5.62%
post 1.64
$9.8M
Mkt cap
$2.1M
Q2 FY26
$187,546
Revenue
$2M
Q2 FY26
Change
Change
DARE
0.65
▲
+4.10%
vs
OBAI
1.68
▼
−5.62%
Closed
Nov 6 '26